Publications & Abstracts
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this...
Safety Experience with the Duodenal-Jejunal Bypass Liner: An Endoscopic Treatment for Diabetes and Obesity
The duodenal-jejunal bypass liner (DJBL) is a new, device-based endoscopic treatment for type 2 diabetes mellitus (T2DM) and obesity.
Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)
On July 30, 2015, GI Dynamics (GID) announced that the clinical study (“Endo Trial”) conducted in the USA would be terminated with...
The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, A Multicenter Randomized Controlled Trial
Investigate the safety and efficacy of 6 months’ duodenal-jejunal bypass liner (DJBL) treatment in comparison with dietary intervention for...
The Acute Effect of Endobarrier Treatment on Glucose Homeostasis in Obese Uncontrolled Diabetic Subjects
The Endobarrier gastrointestinal liner system (by GI Dynamics®) is an endoscopically-delivered device that offers an alternative to gastric bypass...
Endoscopic, Duodenal-Jejunal Bypass Liner Exerts Robust Improvement in Glycemia and Body Weight in Obese Patients with Type 2 Diabetes
The endoscopically delivered duodenal-jejunal bypass liner (DJBL) exhibits robust metabolic effects in obese subjects with type 2 diabetes...
Duodenal-Jejunal Bypass Liner Implantation Provokes Rapid Weight Loss and Improved Glycemic Control, Accompanied by Elevated Fasting Ghrelin Levels
Endoscopic implantation of a duodenal-jejunal bypass liner (DJBL) is a novel bariatric technique to induce weight loss and remission of type 2...
The Feasibility of Delivering a Duodenal-Jejunal Bypass Liner (EndoBarrier®) Endoscopically with Patients Under Conscious Sedation
This study was performed to determine the safety, efficacy, and feasibility of delivering the DJBL with the patient under conscious sedation...
Position Paper of Scientific Societies for Recommended Usage of Endoscopic Biliodigestive Diversion in Germany – DDG/DGAV/DGVS
We recommend consideration of the DJBS as a therapy alternative for the treatment of adult patients (minimum age: 18 years) with type 2 diabetes...
Role of Proximal Gut Exclusion from Food on Glucose Homeostasis in Patients with Type 2 Diabetes
To report Type 2 diabetes-related outcomes after the implantation of a duodenal-jejunal bypass liner device and to investigate the role of proximal...